Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1016 participants.
Also called NCT02247128
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 1,016 participants
- Sponsor
- Registry
-
NCT02247128
-
- Other papers using this trial's data
- Anticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve Implantation
- Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Belgium, Czechia, Luxembourg, Netherlands
- Registry status
- Completed
Technical summary
Registry record NCT02247128. Randomized; no masking; primary purpose prevention. Start 2014-01 (registry gives no type); primary completion 2020-03 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation
- Acronym
- POPular-TAVI
- Condition
- Aortic Valve Disease
- Condition
- Myocardial Infarction
- Condition
- Stroke
- Condition
- Bleeding
- Intervention (Drug)
- Aspirin + clopidogrel
- Intervention (Drug)
- Aspirin monotherapy
- Intervention (Drug)
- OAC + clopicogrel
- Intervention (Drug)
- OAC monotherapy
- Lead sponsor
- St. Antonius Hospital
Record details
- Record id
cardio:ct-nct02247128- Content hash
dcb9577cda8fd6a8aa85ea37611302940cdc39bbbed41fdc403cf0e04cdd4276